RU98118184A - PEPTIDE IMMUNOGEN FOR VACCINATION AND TREATMENT OF ALLERGIES - Google Patents
PEPTIDE IMMUNOGEN FOR VACCINATION AND TREATMENT OF ALLERGIESInfo
- Publication number
- RU98118184A RU98118184A RU98118184/04A RU98118184A RU98118184A RU 98118184 A RU98118184 A RU 98118184A RU 98118184/04 A RU98118184/04 A RU 98118184/04A RU 98118184 A RU98118184 A RU 98118184A RU 98118184 A RU98118184 A RU 98118184A
- Authority
- RU
- Russia
- Prior art keywords
- peptide
- bsw17
- fragment
- mimeotope
- gly
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title claims 11
- 206010020751 Hypersensitivity Diseases 0.000 title claims 2
- 238000002255 vaccination Methods 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 claims 5
- 238000004132 cross linking Methods 0.000 claims 4
- 230000027455 binding Effects 0.000 claims 3
- 239000000969 carrier Substances 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- 235000001014 amino acid Nutrition 0.000 claims 2
- 108090001123 antibodies Proteins 0.000 claims 2
- 102000004965 antibodies Human genes 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 102000037240 fusion proteins Human genes 0.000 claims 2
- 108020001507 fusion proteins Proteins 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- 125000001433 C-terminal amino-acid group Chemical group 0.000 claims 1
- 230000035693 Fab Effects 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000000240 adjuvant Effects 0.000 claims 1
- 201000005794 allergic hypersensitivity disease Diseases 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000001404 mediated Effects 0.000 claims 1
- 102000005614 monoclonal antibodies Human genes 0.000 claims 1
- 108010045030 monoclonal antibodies Proteins 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229960005486 vaccines Drugs 0.000 claims 1
Images
Claims (11)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9604412.8A GB9604412D0 (en) | 1996-03-01 | 1996-03-01 | Organic compounds |
GB9604412.8 | 1996-03-01 | ||
GB9617702.7 | 1996-08-22 | ||
GBGB9617702.7A GB9617702D0 (en) | 1996-08-22 | 1996-08-22 | Organic compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
RU98118184A true RU98118184A (en) | 2000-10-20 |
RU2193413C2 RU2193413C2 (en) | 2002-11-27 |
Family
ID=26308839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU98118184/14A RU2193413C2 (en) | 1996-03-01 | 1997-02-28 | Peptide immunogens for vaccination and treatment of allergy |
Country Status (25)
Country | Link |
---|---|
US (1) | US6610297B1 (en) |
EP (1) | EP0885244B2 (en) |
JP (2) | JP3421970B2 (en) |
KR (2) | KR100498198B1 (en) |
CN (1) | CN1174998C (en) |
AT (1) | ATE230417T1 (en) |
AU (1) | AU719609B2 (en) |
BR (1) | BR9707819A (en) |
CA (1) | CA2245497C (en) |
CY (1) | CY2457B1 (en) |
CZ (1) | CZ299551B6 (en) |
DE (1) | DE69718150T3 (en) |
DK (1) | DK0885244T4 (en) |
ES (1) | ES2190799T5 (en) |
HK (1) | HK1014962A1 (en) |
HU (1) | HUP9901109A3 (en) |
IL (1) | IL125590A (en) |
NO (1) | NO321043B1 (en) |
NZ (1) | NZ331651A (en) |
PL (1) | PL187209B1 (en) |
RU (1) | RU2193413C2 (en) |
SI (1) | SI0885244T2 (en) |
SK (1) | SK284856B6 (en) |
TR (1) | TR199801722T2 (en) |
WO (1) | WO1997031948A1 (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6913749B2 (en) | 1998-11-02 | 2005-07-05 | Resistentia Pharmaceuticals Ab | Immunogenic polypeptides for inducing anti-self IgE responses |
EP1621209A3 (en) * | 1998-11-02 | 2006-04-19 | Resistentia Pharmaceuticals AB | Vaccines based on domains of chimeric immunoglobulin E peptides |
IL143441A0 (en) | 1998-11-30 | 2002-04-21 | Cytos Biotechnology Ag | Non-naturally occuring antigen arrays and processes for the preparation thereof |
NZ513680A (en) * | 1999-02-25 | 2001-09-28 | Peptide Therapeutics Ltd | Epitodes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of IgE, antagonists thereof, and their therapeutic uses |
EP1156825A2 (en) * | 1999-02-25 | 2001-11-28 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Immunogens comprising a peptide and a carrier derived from h.influenzae protein d |
GB9908533D0 (en) * | 1999-04-14 | 1999-06-09 | Novartis Ag | Organic compounds |
IL152054A0 (en) * | 2000-04-13 | 2003-05-29 | Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh | Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells |
EP1278542A2 (en) | 2000-05-05 | 2003-01-29 | Cytos Biotechnology AG | Molecular antigen arrays and vaccines |
EP1967205B1 (en) | 2000-08-30 | 2012-10-10 | Pfizer Products Inc. | Anti-IgE vaccines |
US7128911B2 (en) | 2001-01-19 | 2006-10-31 | Cytos Biotechnology Ag | Antigen arrays for treatment of bone disease |
US7264810B2 (en) | 2001-01-19 | 2007-09-04 | Cytos Biotechnology Ag | Molecular antigen array |
US7094409B2 (en) | 2001-01-19 | 2006-08-22 | Cytos Biotechnology Ag | Antigen arrays for treatment of allergic eosinophilic diseases |
ES2394293T3 (en) * | 2001-02-28 | 2013-01-30 | Bio Life Science Forschungs- Und Entwicklungsges.M.B.H. | Vaccine against cancers that are associated with the HER-2 / neu oncogene |
EP1239032A1 (en) | 2001-03-02 | 2002-09-11 | Société des Produits Nestlé S.A. | Lactic acid bacteria as agents for treating and preventing allergy |
JP2003047482A (en) | 2001-05-22 | 2003-02-18 | Pfizer Prod Inc | IgE VACCINE FREE FROM ANAPHYLAXIS-INDUCING PROPERTY |
EP1497654A4 (en) | 2001-08-13 | 2006-06-07 | Chen Swey Shen Alex | Immunoglobulin e vaccines and methods of use thereof |
US7115266B2 (en) | 2001-10-05 | 2006-10-03 | Cytos Biotechnology Ag | Angiotensin peptide-carrier conjugates and uses thereof |
US20050226894A1 (en) * | 2002-01-15 | 2005-10-13 | Jensen-Jarolim Erika | Oral vaccination |
AU2003246690B2 (en) | 2002-07-17 | 2010-03-11 | Cytos Biotechnology Ag | Molecular antigen arrays using a virus like particle derived from the AP205 coat protein |
BR0312297A (en) | 2002-07-18 | 2005-04-12 | Cytos Biotechnology Ag | Conjugated hapten vehicles and their use |
KR101070078B1 (en) | 2002-07-19 | 2011-10-04 | 노파르티스 파르마 아게 | 1-6 Vaccine Compositions Containing Amyloid Beta1-6 Antigen Arrays |
US7425619B2 (en) | 2002-08-14 | 2008-09-16 | Macrogenics, Inc. | FcγRIIB specific antibodies and methods of use thereof |
US20050065136A1 (en) * | 2003-08-13 | 2005-03-24 | Roby Russell R. | Methods and compositions for the treatment of infertility using dilute hormone solutions |
WO2005105106A2 (en) * | 2004-04-21 | 2005-11-10 | Roby Russell R | Hormone treatment of macular degeneration |
US20060025390A1 (en) * | 2004-07-28 | 2006-02-02 | Roby Russell R | Treatment of hormone allergy and related symptoms and disorders |
ITMI20052517A1 (en) * | 2005-12-29 | 2007-06-30 | Lofarma Spa | VARIANBTIO HYPOALLERGENICS OF ALLERGENE GREATER BET V 1 BERRY OF BETULA VERRUCOSA |
ES2599319T3 (en) | 2006-06-26 | 2017-02-01 | Macrogenics, Inc. | Fc RIIB specific antibodies and their methods of use |
EP2012122A1 (en) * | 2007-07-06 | 2009-01-07 | Medigene AG | Mutated parvovirus structural proteins as vaccines |
US8865179B2 (en) * | 2008-01-26 | 2014-10-21 | Swey-Shen Alexchen | Aptameric IgE peptides in a protein scaffold as an allergy vaccine |
ES2622562T3 (en) | 2008-12-09 | 2017-07-06 | Pfizer Vaccines Llc | IgE CH3 peptide vaccine |
WO2011154878A1 (en) | 2010-06-07 | 2011-12-15 | Pfizer Vaccines Llc | Ige ch3 peptide vaccine |
RU2761431C9 (en) * | 2020-10-26 | 2022-04-18 | Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) | Recombinant polypeptide based on birch pollen allergen and apple allergen as an allergy vaccine |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2602443A1 (en) | 1975-04-04 | 1976-10-21 | Univ California | BIOLOGICALLY ACTIVE POLYPEPTIDES |
US4171299A (en) | 1975-04-04 | 1979-10-16 | The Regents Of The University Of California | Polypeptide agents for blocking the human allergic response |
DE2861593D1 (en) | 1977-06-29 | 1982-03-11 | Beecham Group Plc | Peptides, pharmaceutical compositions containing the peptides and a process for the preparation of the peptides |
JPS5944399A (en) | 1982-09-07 | 1984-03-12 | Takeda Chem Ind Ltd | Novel dna |
GB8616166D0 (en) * | 1986-07-02 | 1986-08-06 | Research Corp Ltd | Polypeptide competitor |
US4892827A (en) | 1986-09-24 | 1990-01-09 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects |
EP0269455A3 (en) | 1986-11-28 | 1989-09-06 | Takeda Chemical Industries, Ltd. | Highly purified fused protein comprising human ige fc fragment and production thereof |
JPH02502183A (en) | 1987-02-20 | 1990-07-19 | インクローン システムズ、インコーポレーテッド | Monoclonal antibodies in vaccine formulation |
CA1336818C (en) | 1987-04-16 | 1995-08-29 | International Institute Of Cellular And Molecular Pathology | Treatment of allergy and composition thereof |
KR890701761A (en) | 1987-10-13 | 1989-12-21 | 제롤드 엘.글릭 | Method of Preparation of Immune Diagnostic Reagent |
GB8727045D0 (en) | 1987-11-19 | 1987-12-23 | Research Corp Ltd | Immunoglobulin e competitor |
US5449760A (en) | 1987-12-31 | 1995-09-12 | Tanox Biosystems, Inc. | Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils |
US5342924A (en) | 1987-12-31 | 1994-08-30 | Tanox Biosystems, Inc. | Extracellular segments of human ε immunoglobulin anchoring peptides and antibodies specific therefor |
GB8910263D0 (en) | 1989-05-04 | 1989-06-21 | Ciba Geigy Ag | Monoclonal antibodies specific for an immunoglobulin isotype |
GB8913737D0 (en) * | 1989-06-15 | 1989-08-02 | Univ Birmingham | A novel anti-allergy treatment |
WO1991011456A1 (en) | 1990-01-23 | 1991-08-08 | Tanox Biosystems, Inc. | EXTRACELLULAR SEGMENTS OF HUMAN ε IMMUNOGLOBULIN ANCHORING PEPTIDES AND ANTIBODIES SPECIFIC THEREFOR |
DE69112225T2 (en) | 1990-05-25 | 1996-01-04 | Peptide Therapeutics Ltd | IMMUNODIAGNOSTIC SAMPLE FOR JOINT CRHEUMATISM. |
US5258289A (en) | 1990-09-05 | 1993-11-02 | Davis Claude G | Method for the selecting of genes encoding catalytic antibodies |
GB9101550D0 (en) | 1991-01-24 | 1991-03-06 | Mastico Robert A | Antigen-presenting chimaeric protein |
US5965709A (en) * | 1991-08-14 | 1999-10-12 | Genentech, Inc. | IgE antagonists |
ES2193136T3 (en) * | 1991-08-14 | 2003-11-01 | Genentech Inc | IMMUNOGLUBINE VARIANTS FOR SPECIFIC RECEIVERS OF FC EPSILON. |
SE9102808L (en) | 1991-09-26 | 1993-03-27 | Lars T Hellman Inst F Immunolo | VACCIN, HOW TO USE HUMAN USE, WILL BE INTENDED TO EFFECT THE SYMPTOMS OR PREVENT THE RISE OF IGE-MEDIATED ALLERGIC REACTIONS |
GB9125024D0 (en) | 1991-11-25 | 1992-01-22 | Kirby Julian | Rheumatoid arthritus treatment |
JPH06113881A (en) | 1992-10-07 | 1994-04-26 | Snow Brand Milk Prod Co Ltd | Human type monoclonal antipeptide antibody and dna capable of coding the same |
US5759551A (en) | 1993-04-27 | 1998-06-02 | United Biomedical, Inc. | Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines |
ES2180576T3 (en) | 1993-04-27 | 2003-02-16 | United Biomedical Inc | PEPTIDIC CONSTRUCTIONS OF LHRH IMMUNOGENIC AND UNIVERSAL SYNTHETIC IMMUNITY STIMULATORS FOR VACCINES. |
WO1994026723A2 (en) | 1993-05-14 | 1994-11-24 | Genentech, Inc. | ras FARNESYL TRANSFERASE INHIBITORS |
GB9320897D0 (en) | 1993-10-11 | 1993-12-01 | Peptide Therapeutics Ltd | Compounds useful in anti-allergy treatment |
GB9324013D0 (en) * | 1993-11-22 | 1994-01-12 | 3I Res Expl Ltd | Polypeptides |
FR2715304B1 (en) * | 1994-01-26 | 1996-04-26 | Merieux Serums Vaccins Pasteur | Anti-allergic vaccine. |
JPH09510975A (en) | 1994-03-28 | 1997-11-04 | ユナイテッド・バイオメディカル・インコーポレイテッド | Synthetic peptide-based immunogen for the treatment of allergies |
WO1996001643A1 (en) | 1994-07-08 | 1996-01-25 | Thomas Jefferson University | IgE ANTAGONISTS |
EP0787150A1 (en) | 1994-10-25 | 1997-08-06 | United Biomedical, Inc. | SYNTHETIC IgE MEMBRANE ANCHOR PEPTIDE IMMUNOGENS FOR THE TREATMENT OF ALLERGY |
AU6532498A (en) | 1996-12-06 | 1998-06-29 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Inhibition of ige-mediated allergies by a human ige-derived oligopeptide |
EP0955311A3 (en) | 1998-04-09 | 2000-08-16 | Idexx Laboratories, Inc. | Peptide vaccine for canine allergy |
TWI229679B (en) | 1998-06-20 | 2005-03-21 | United Biomedical Inc | Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
-
1997
- 1997-02-28 RU RU98118184/14A patent/RU2193413C2/en not_active IP Right Cessation
- 1997-02-28 CZ CZ0277198A patent/CZ299551B6/en not_active IP Right Cessation
- 1997-02-28 CA CA002245497A patent/CA2245497C/en not_active Expired - Fee Related
- 1997-02-28 DK DK97905136T patent/DK0885244T4/en active
- 1997-02-28 JP JP53063297A patent/JP3421970B2/en not_active Expired - Fee Related
- 1997-02-28 CN CNB971926719A patent/CN1174998C/en not_active Expired - Fee Related
- 1997-02-28 HU HU9901109A patent/HUP9901109A3/en unknown
- 1997-02-28 NZ NZ331651A patent/NZ331651A/en unknown
- 1997-02-28 TR TR1998/01722T patent/TR199801722T2/en unknown
- 1997-02-28 AU AU18796/97A patent/AU719609B2/en not_active Ceased
- 1997-02-28 WO PCT/EP1997/001013 patent/WO1997031948A1/en active IP Right Grant
- 1997-02-28 KR KR10-1998-0706845A patent/KR100498198B1/en not_active IP Right Cessation
- 1997-02-28 BR BR9707819A patent/BR9707819A/en not_active Application Discontinuation
- 1997-02-28 DE DE69718150T patent/DE69718150T3/en not_active Expired - Lifetime
- 1997-02-28 US US09/125,641 patent/US6610297B1/en not_active Expired - Fee Related
- 1997-02-28 AT AT97905136T patent/ATE230417T1/en not_active IP Right Cessation
- 1997-02-28 SK SK1181-98A patent/SK284856B6/en unknown
- 1997-02-28 PL PL97328858A patent/PL187209B1/en not_active IP Right Cessation
- 1997-02-28 ES ES97905136T patent/ES2190799T5/en not_active Expired - Lifetime
- 1997-02-28 EP EP97905136A patent/EP0885244B2/en not_active Expired - Lifetime
- 1997-02-28 SI SI9730490T patent/SI0885244T2/en unknown
- 1997-02-28 KR KR1020057005577A patent/KR100584051B1/en not_active IP Right Cessation
- 1997-02-28 IL IL12559097A patent/IL125590A/en not_active IP Right Cessation
-
1998
- 1998-08-31 NO NO19983999A patent/NO321043B1/en unknown
- 1998-12-31 HK HK98119259A patent/HK1014962A1/en not_active IP Right Cessation
-
2002
- 2002-12-26 JP JP2002377664A patent/JP2003231696A/en active Pending
-
2004
- 2004-06-04 CY CY0400044A patent/CY2457B1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU98118184A (en) | PEPTIDE IMMUNOGEN FOR VACCINATION AND TREATMENT OF ALLERGIES | |
EP0117934B1 (en) | Antigenic modification of polypeptides | |
CA2290485A1 (en) | Method for the production of non-immunogenic proteins | |
KR900701836A (en) | Peptides useful for diagnosing, preventing or treating new HIV proteins and AIDS | |
EP1630229A3 (en) | Melanoma antigens | |
KR950702839A (en) | Retro, Inverso-, and Retro-Inverso Synthetic Peptide Analogues (RETRO-, INVERSO-, AND RETRO-INVERSO SYNTHETIC PEPTIDE ANALOGUES) | |
ATE244891T1 (en) | METHOD FOR SELECTION AND PRODUCTION OF T-CELL PEPTIDES EPITOPES AND VACCINES WITH THESE EPITOPES | |
PT97159A (en) | A process for the preparation of a hepatitis B surface antigen or a fragrance thereof and a method for the preparation of a vaccine | |
RU2002113920A (en) | ANTIGENIC PEPTIDES NEISSERIA | |
RU2002104700A (en) | Fc proteins with immunoglobulin Fc fragment to increase the immunogenicity of protein and peptide antigens | |
ATE107313T1 (en) | SYNTHETIC PSEUDOMONAS AERUGINOSA PILIN PEPTIDE AND RELATED VACCINES AND DIAGNOSTICS. | |
WO1996021734A3 (en) | P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods | |
UY24130A1 (en) | PEPTIDO P277 ANALOGS AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM FOR THE TREATMENT OR DIAGNOSIS OF DIABETES. | |
DE68925660D1 (en) | HIV peptide fragments | |
Elsayed et al. | Epitope mapping of region 11–70 of ovalbumin (Gal d I) using five synthetic peptides | |
AU707083B2 (en) | Inducing antibody response against self-proteins with the aid of foreign T-cell epitopes | |
US4483793A (en) | Dimeric oligopeptides as heptenic epitopic sites for hepatitis | |
Buchanan-Davidson et al. | Immunochemistry of Synthetic Polypeptides and Polypeptidyl Proteins: III. Antigenicity of the Synthetic Polypeptides | |
KR910000179A (en) | Conjugate immunogen for AIDS | |
JPS62502340A (en) | Immune antibody-carrier protein conjugate for use in vaccines against malaria | |
ATE327251T1 (en) | METHOD OF REDUCING THE IMMUNOGENICITY OF STAPHYLOKINASE BY REMOVAL OF T-CELL EPITOPES | |
ATE103294T1 (en) | PEPTIDE FRAGMENTS OF HIV. | |
KR930703444A (en) | Fish progesterone-releasing hormone homologue | |
Aas | Common characteristics of major allergens | |
AU4712993A (en) | New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods |